Drugs Made In America Acquisition II Corp. (DMIIU) Assets Average (2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Assets Average of $503.0 million for Q4 2025, up 100.73% quarter-over-quarter from $250.6 million in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Assets Average (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Assets Average for 1 consecutive years, with $503.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average changed N/A year-over-year to $503.0 million; the TTM figure through Dec 2025 stood at $503.0 million (changed N/A YoY), while the FY2025 annual figure was $252.5 million, changed N/A from the prior year.
- Assets Average rose to $503.0 million in Q4 2025 per DMIIU's latest filing, from $250.6 million in the prior quarter.
- Across five years, Assets Average topped out at $503.0 million in Q4 2025 and bottomed at $250.6 million in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 502.98 Mn |
| Sep 30, 2025 | 250.57 Mn |